Señales en vivo de TENX | Maximiza tus Ganancias con Getagraph.com

COMPRAR 124174 min ago

@ $4.72

Emitido: 13 feb 2024 @ 09:30

Retorno: -24.38%

Señal anterior: feb 12 - 10:27

Señal anterior: Vender

Retorno: -6.14 %

Live Chart Being Loaded With Signals

Commentary (9 may 2024 @ 15:59):

Stats
Volumen de hoy	10 928.00
Volumen promedio	117 590
Capitalización de mercado	6.99M
EPS	$0 ( 2024-04-01 )
Próxima fecha de ganancias	( $-2.40 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0.0270 (0.76%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-11	Hoffman Lawrence R	Sell	0	Common Stock
2022-09-21	Rich Stuart	Buy	1 909 585	Common Stock
2022-09-21	Rich Stuart	Sell	1 909 585	Common Stock
2022-08-11	Doogan Declan	Sell	567 871	Common Stock
2022-06-09	Rich Stuart	Buy	100 000	Stock Option (right to buy)

INSIDER POWER
19.12
Last 92 transactions
Buy: 35 341 052 \| Sell: 26 670 670

Volumen Correlación

Largo: -0.07 (neutral)

Corto: 0.67 (moderate)

Signal:(46.95) Neutral

Tenax Therapeutics Inc Correlación

10 Correlaciones Más Positivas
VRM	0.947
LGVN	0.94
EBIX	0.939
VRAY	0.938
RIDE	0.938
TVACW	0.936
AGRI	0.935
SRNGW	0.933
KSPN	0.932
REVB	0.927

10 Correlaciones Más Negativas
TIOA	-0.943
MSDA	-0.939
NVCN	-0.938
BRIVU	-0.937
SILK	-0.934
SGII	-0.932
BRIV	-0.929
PRAX	-0.927
ALOR	-0.921
STAY	-0.919

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Tenax Therapeutics Inc Correlación - Moneda/Commodity

0.22
( neutral )

0.23
( neutral )

0.00
( neutral )

-0.37
( neutral )

-0.29
( neutral )

-0.02
( neutral )

Tenax Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-7 570.00 (0.00 %)
EPS:	$-31.04

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-7 570.00 (0.00 %)
EPS:	$-31.04

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-113 332 (0.00 %)
EPS:	$-600.46

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.580

Financial Reports:

No articles found.

Tenax Therapeutics Inc

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.